I’m considering whether there is enough interest to organize a traditional Group Buy. To be clear, this would not be a consolidated order and it would not be a rolling threshold model. This would be a standard Group Buy structure: MOQ requirement (Minimum Order Quantity) Specific product list Specific vendor Specific ordering window Specific close date Testing structure stated Before I put any effort into vendor discussions, pricing, or testing options, I’d like to get member feedback first. If the feedback is strong enough, we can pursue it. If interest is very limited, I’ll abandon the concept for now. Two questions: 1. What products would you like to see considered? 2. Is there interest in exploring a traditional Group B format if the right product list comes together? Drop your thoughts below. Product suggestions do not guarantee they will be included, but they will help determine whether this is worth exploring.

This morning we talked about GLOW / KLOW blends from the practical side. Convenience vs control. One vial is easy. Separate vials give you more control. But there is another issue most never even think about: pH balance. And no, this is not chemistry class for the sake of chemistry class. This matters because once a peptide is reconstituted, it is no longer just “powder in a Vial.” It is now sitting in a liquid environment and a liquid environment has a pH, it has a buffer profile, it has storage conditions and it has preservatives. When you blend multiple peptides into one vial, all of those peptides are now forced to live in the same chemical environment. That is the part people may not and mostly do not consider. The Blend Question Is Not Just Biology Most people ask: “Do these peptides work well together?” That is a biology question. But with blends, there is another question: Do these peptides behave well together chemically in the same vial over time? That is the formulation question. · Because each peptide brings its own chemistry into the vial. · Its own amino acid chain. · Its own charge profile. · Its own stability preference. · Its own sensitivity to pH, buffer, concentration, temperature, and time. So when several peptides are blended together, they are not magically neutral. They are now competing inside one shared liquid environment. And depending on the peptide, concentration, counterions, buffer system, and formulation, one part of that blend may dominate the pH balance more than the others. That is the part people miss. The problem is not just: “Are these peptides useful together?” The better question is: “What happens when these different peptide chemistries are forced to sit together in the same vial?” Simple pH Reality Check Here is the basic picture: Peptide pH Zone / Range Character BPC-157 ~ 6.5–7.5 preferred for injectable formulation Robust / near-neutral friendly GHK-Cu ~ 4.5–7.4 Mildly acidic to neutral TB-500 / TB4 ~5.0–6.0 Prefers mildly acidic

Retatrutide Promotional Consolidated Group Buy Vendor: TRANMOO Peptide 📅 Dark Horse Enrollment Period: July 1, 2026 – July 15, 2026 ⚠️ Vendor Promotion: Available while supplies last. If the vendor promotion ends or inventory sells out before July 15, this opportunity will close early. The Dark Horse Perspective A promotional opportunity recently crossed my desk that caught my attention because of the current pricing—particularly Retatrutide. Price is what initially caught my attention, but price alone should never be the deciding factor. As always, I encourage members to review the available documentation, ask questions, and perform their own due diligence before participating. I'm opening this as a Dark Horse Consolidated Group Buy so participants can share the vendor's shipping cost. Promotional Pricing (1 Kit = 10 Vials) Product Vendor Price Retatrutide 10mg $66 Retatrutide 20mg $87 Retatrutide 40mg $138 HGH Frag 5mg $115 Tesamorelin 10mg $132 Ipamorelin 10mg $50 GHK-Cu 100mg $35 GHK-Cu 50mg $31 What I Reviewed Before Posting This promotion included Certificates of Analysis (COAs) for only a few of the promoted products. I looked for additional supporting documentation, but the available information just was not there. Update July 2nd - Testing disclosure: Tranmoo has confirmed that no COA is currently available for Ipamorelin 10 mg. Participants requesting Ipamorelin have been informed and have chosen to remain in the order. While a COA should never be the sole basis for evaluating a vendor, I appreciate vendors who make analytical documentation available for review. As always, I encourage everyone to review the available documentation, perform their own due diligence, and make informed decisions based on their own research standards and risk tolerance. Group Buy Activation This group buy will be activated once $350 USD in confirmed product selections has been reached. Once activated: - Invoices will be issued to all participants. - Payment is due within 24 hours of invoice issuance. - The order will be submitted to the vendor once all funds have been collected.

KPV 30mg - Not! KP17 purity =99.7% mass =17.56MG Significant underfill Take a look at the attached dialog around independent third-party lab testing. This group buy had a vendor-supplied COA. But instead of relying only on the vendor’s paperwork, the group formed its own testing pool, split the cost, and sent product out for independent lab testing. They tested for: ID / Mass / Purity That matters. Because trust cannot be based on labels, vendor COAs, or vendor promises alone. A product can come back with great purity and still be underfilled. High purity does not automatically mean proper fill. A vial can test clean and still be underdosed. That is the part many people miss. This is exactly why I keep coming back to independent third-party testing. It is personal risk tolerance. For me, verification will always matter more than assumption.

The public chatter around the gray-market peptide supply chain is starting to sound different. In the prior testing discussion, the comment was made that raws are becoming harder to get, product is being lost at borders, manufacturers may be shutting down, and that things have changed drastically since February. Is that official proof of anything? No. But it is Chatter that is getting stronger within the gray market and worth paying attention to. Public forum chatter is not proof, but it is a signal. When the same types of comments start showing up across different communities, vendors, and buyers, it usually means there is pressure somewhere in the system. That pressure may show up as: longer shipping times: more reships: inventory gaps: price changes: vendor delays: inconsistent fills: different batch quality : more supplier excuses. My Summation - The supply chain is not as stable or predictable as people sometimes assume. And that matters. Because in this space, most people only see the final vial. We do not see the raw material sourcing, manufacturer problems or customs losses. We do not see vendor substitution, batch-to-batch changes, since there is no real chain of custody in gray. That is why I pay attention to public chatter, even when I do not treat it as proof. It is not evidence by itself. But it can be an early warning signal that one can pay attention too. And right now, some of the chatter is starting to sound repetitive enough to pay attention. For me personally, that means: More caution, More verification, Never Assumption